ISRG's da Vinci 5 begins international rollout, but pricing sensitivity, budgets, and reimbursement hurdles could slow adoption outside the United States.
Trilogy Capital Inc. increased its stake in Intuitive Surgical, Inc. (NASDAQ: ISRG) by 23.8% in the third quarter, according to the company in its most recent disclosure with the SEC. The institutiona
Intuitive Surgical, Inc. (NASDAQ: ISRG - Get Free Report) has been given a consensus recommendation of "Moderate Buy" by the twenty-seven research firms that are covering the firm, MarketBeat reports.
ISRG is positioning da Vinci 5 as a TAM expander, targeting cardiac surgery long term while advancing near-term regulatory steps in general surgery.
Intuitive Surgical, Inc. dominates surgical robotics with an 80% global share and a robust, recurring-revenue business model anchored by the da Vinci platform. ISRG's installed base and procedure volu
The latest trading day saw Intuitive Surgical, Inc. (ISRG) settling at $585.08, representing a -1.21% change from its previous close.
Intuitive Surgical (ISRG) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
ISRG trades just 4% below its record high after a 32% surge over the past three months, driven by strong procedure growth, rising utilization, and early traction for the da Vinci 5 system.

Is ISRG Stock Still A Buy At $600?

08:45am, Wednesday, 07'th Jan 2026
ISRG stock has climbed nearly 40% from its October 2025 lows of approximately $425, currently trading near $590. What has spurred this remarkable rise?
Intuitive Surgical is a leading provider of surgical robotics devices. Its da Vinci robot was one of the first to market and boasts a massive installed base.
Robotics is poised for steady growth in 2026. Consider PATH, NVDA, CDNS and ISRG for potential market dominance across sectors.
Eli Lilly highlights how AI is transforming healthcare, from drug discovery to diagnostics, turning defensive medical stocks into growth plays for 2026.

2 Soaring Stocks to Hold for the Next 20 Years

02:30am, Tuesday, 06'th Jan 2026
Growth companies are usually afforded a premium by the market. If you hold for the long term, say a 20-year period, a company's growth can compensate for a lofty valuation at the time of purchase.
This selection of stocks offers interesting buys throughout industries -- from tech to healthcare. Many of these players are trading at bargain levels.
LLY, MDT, ISRG, REGN and JNJ are five defensive medical stocks using AI to drive growth, diagnostics and innovation into 2026.
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE